Leukemia, Myeloid [clinicaltrials_resource:34f22f570aedc5ec3cb0f962962465e9]
clinicaltrials:NCT00025662Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation [clinicaltrials:NCT00030186]Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome [clinicaltrials:NCT00065143]Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML) [clinicaltrials:NCT00129168]A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia [clinicaltrials:NCT00233909]T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation [clinicaltrials:NCT00306332]Analyses of Human Samples Collected in Clinical Trials [clinicaltrials:NCT00339664]clinicaltrials:NCT00451997Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia [clinicaltrials:NCT00512083]Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML [clinicaltrials:NCT00568633]clinicaltrials:NCT00611247clinicaltrials:NCT01050036Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome and /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase [clinicaltrials:NCT01061177]Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias [clinicaltrials:NCT01144793]Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders [clinicaltrials:NCT01392989]Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients [clinicaltrials:NCT01511289]Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI [clinicaltrials:NCT01602952]clinicaltrials:NCT02333838clinicaltrials:NCT02370888
condition [clinicaltrials_vocabulary:condition]
Trial to Reduce Alloimmunization to Platelets (TRAP) [clinicaltrials:NCT00000589]Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia [clinicaltrials:NCT00001144]Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00002549]Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse [clinicaltrials:NCT00002554]Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002574]Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002592]Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002598]Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00002658]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002674]Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia [clinicaltrials:NCT00002693]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002761]clinicaltrials:NCT00002768Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002771]Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00002789]Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002800]clinicaltrials:NCT00002805High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies [clinicaltrials:NCT00002818]clinicaltrials:NCT00002832clinicaltrials:NCT00002833Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002868]Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002869]Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00002890]Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [clinicaltrials:NCT00002926]High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00002945]Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003003]clinicaltrials:NCT00003005CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse [clinicaltrials:NCT00003131]Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00003145]Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia [clinicaltrials:NCT00003148]clinicaltrials:NCT00003178Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00003190]Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003230]clinicaltrials:NCT00003239Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003255]Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT00003268]Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003340]Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003405]Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003407]
condition browse [clinicaltrials_vocabulary:condition-browse]
Trial to Reduce Alloimmunization to Platelets (TRAP) [clinicaltrials:NCT00000589]Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia [clinicaltrials:NCT00001144]Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00002549]Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse [clinicaltrials:NCT00002554]Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002574]Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002592]Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002598]Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00002658]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002674]Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia [clinicaltrials:NCT00002693]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002761]clinicaltrials:NCT00002768Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002771]Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00002789]Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002798]Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00002800]clinicaltrials:NCT00002805High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies [clinicaltrials:NCT00002818]clinicaltrials:NCT00002832clinicaltrials:NCT00002833Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002868]Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [clinicaltrials:NCT00002869]Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00002890]Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [clinicaltrials:NCT00002926]High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00002945]Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003003]clinicaltrials:NCT00003005CMA-676 in Treating Patients With Acute Myeloid Leukemia in First Relapse [clinicaltrials:NCT00003131]Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00003145]Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia [clinicaltrials:NCT00003148]clinicaltrials:NCT00003178Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia [clinicaltrials:NCT00003190]Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003230]clinicaltrials:NCT00003239Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003255]Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT00003268]Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003340]Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003405]Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003407]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Leukemia, Myeloid [clinicaltrials_resource:34f22f570aedc5ec3cb0f962962465e9]
Bio2RDF identifier
34f22f570aedc5ec3cb0f962962465e9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:34f22f570aedc5ec3cb0f962962465e9
identifier
clinicaltrials_resource:34f22f570aedc5ec3cb0f962962465e9
title
Leukemia, Myeloid
@en
type
label
Leukemia, Myeloid [clinicaltrials_resource:34f22f570aedc5ec3cb0f962962465e9]
@en
Leukemia, Myeloid